The amyloid precursor protein forms plasmalemmal clusters via its pathogenic amyloid-β domain

Related Experiment Video

Updated: May 23, 2026

Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain
10:08

Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain

Published on: August 28, 2012

Arne Schreiber1, Sebastian Fischer, Thorsten Lang

  • 1Department of Membrane Biochemistry, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany.

Biophysical Journal
|March 30, 2012
PubMed

Insights

The amyloid-beta (Aβ) domain in amyloid precursor protein (APP) clusters APP in the cell membrane, initiating its own processing. This discovery reveals a physiological role for Aβ in APP trafficking and Alzheimer's disease pathogenesis.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Molecular Biology

Background:

  • Amyloid precursor protein (APP) processing generates amyloid-beta (Aβ) peptides implicated in Alzheimer's disease.
  • The precise physiological role of the Aβ sequence within the intact APP molecule remains incompletely understood.

Purpose of the Study:

  • To investigate the functional role of the Aβ sequence within the unprocessed APP molecule.
  • To elucidate the mechanisms by which APP is trafficked to endocytic pathways.

Main Methods:

  • Analysis of APP localization and clustering in the plasma membrane.
  • Investigation of APP trafficking to clathrin-coated endocytic structures.
  • Biochemical assays to assess protein-protein interactions and membrane dynamics.

Main Results:

  • The Aβ domain of APP concentrates APP molecules into extracellular plasmalemmal clusters.
  • Stabilization of these APP clusters by the Aβ domain is essential for their subsequent targeting to endocytic clathrin structures.
  • This mechanism demonstrates an intrinsic function of the Aβ sequence in regulating APP trafficking.

Conclusions:

  • The Aβ domain directly mediates a critical step in APP trafficking.
  • APP clustering driven by the Aβ domain is a prerequisite for its own conversion into neurotoxic peptides.
  • This finding provides new insights into the early events of APP processing and its link to Alzheimer's disease.

More Related Videos

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP07:55

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Published on: October 17, 2015

Rapid Generation of Amyloid from Native Proteins In vitro05:48

Rapid Generation of Amyloid from Native Proteins In vitro

Published on: December 5, 2013

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial precursors...